chemotherapy news from FierceBioResearcher

San Diego-based Illumina is commercializing three new products aimed at a better understanding of the molecular mechanisms that give rise to cancer. Illumina's DASL Assay is designed to profile Read more...

The notion that cancer stem cells are responsible for much of the worst damage associated with the disease took another step forward with the release of a new study from Harvard Medical School that Read more...

Researchers from Ludwig-Maximilians-University in Munich have determined that cancer stem cells govern metastasis in pancreatic cancer as well as making tumors resistant to chemotherapy. Patrick Read more...

Tiny fat bubbles can be used to deliver powerful chemotherapy drugs to the site of tumors. Investigators at Duke University have been injecting chemotherapy into fat liposomes and injecting them Read more...

Germany's MediGene grabbed the headlines at a conference in Switzerland recently with new efficacy data from a Phase I/II trial of a genetically engineered herpes virus designed to kill cancer cells. Read more...

A pair of scientists at the University of Oklahoma say they have developed a fusion protein that can prevent the spread of cancer. The fusion protein blocks cancer cells from ingesting methionine, a protein they need to develop. The researchers have developed a mechanism that delivers the compound directly to cancer cells, avoiding any damage to healthy cells. The research fits into a broad range of programs looking to develop new ways to deliver cancer therapies without harming healthy …

Read more...

An Australian biotech company says it has developed a "nano-cell" that can be used to directly deliver drugs to cancer cells. Reporting in Cancer Cell journal, EnGeneIC reports the approach worked in primates and promises to help greatly reduce the amount of cancer therapies needed for treatment, while avoiding many of the harsh side effects that are common to chemotherapy. The nano-cell relies on antibodies to dock on the cancer cell for targeted delivery. Researchers hope to begin human …

Read more...

New research appearing in the Journal of Biology shows that even low doses of chemotherapy are killing brain cells and cancer drugs are more malignant to healthy cells than diseased cells. The study focused on the effects of cisplatin, cytarabine and carmustine on rats and found that healthy cells were still dying weeks after therapy. And the harsh therapy not only targeted the dividing cells that spread cancer, but normal cells that weren't dividing. The study at the University …

Read more...